While we previously showed that STIM1 specifically influences exogenous TGF-β-induced EMT [52], results in this work further our understanding of the biology of STIM family members in cancer cells and provide a rationale for potential precise targeting for cancer therapy. This evidence concerns the gene STIM1 and cancer.